From Numbers to Knowledge: Unlocking the Predictive Power of Data To Accelerate Transformative Science

Scientists and experts at Bristol Myers Squibb are working to revolutionize the process of drug development with sophisticated scientific strategies driven by technology.

Expanding the Possibilities With Quest Advanced® Neurology

Quest Advanced® Neurology offers a complete neurological testing portfolio, including molecular, biochemical, neuroimmunological, cytogenetic, and pharmacogenomic testing for diagnosing neurological conditions.

Disparities in Breast Cancer Mortality and Treatment Underscore the Importance of Testing

Quest was proud to sponsor Sisters Network Inc. and its first-ever State of Black Breast Cancer Crisis: a National Townhall Virtual Discussion and Call to Action.

How Merck Is Using 3D Printing To Create Innovative Solutions

3D technology is helping optimize workstreams, shorten turn-around times, reduce costs and drive innovation

Gilead Sciences Announces Collaboration With Morehouse School of Medicine and Xavier University of Louisiana College of Pharmacy To Address Inequities in HIV Care

Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new health equity collaboration with the Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine and the Center for

Improving Outcomes for the Leading Cause of Death in the US

Quest has expanded from our original primary focus on heart disease to a multi-pronged proactive approach that focuses on critical diagnostic insights across the cardiometabolic continuum.

Alkermes Looks To Fill Cancer Treatment Gaps With New Immune Pathways

A conversation with Craig Hopkinson

Key Insights on Current and Emerging Healthcare Issues

The Quest Diagnostics Health Trends® series of reports are drawn from our billions of data points to provide key insights into current healthcare issues.

Thought Leadership Marries Insights to Influence

Our original research and critical insights are highlighting the many unanticipated impacts of the pandemic on public health.

IWBI Commends the Passage of the Inflation Reduction Act, 'Landmark Legislation Critical for Planetary Health and Human Health'

Following President Biden’s signature on the Inflation Reduction Act of 2022, the International WELL Building Institute (IWBI), issued the following statement from Rachel Hodgdon, IWBI President and CEO.

Latest Campaigns

  1. Energy Transition
    Energy Transition Content
  2. Mary Kay Ash Foundation: Creating a Safer, Healthier World for Women
    In the U.S. and around the world, Mary Kay remains steadfast in its commitment to ending the cycle of domestic violence and finding cures for cancers...
  3. Protecting our planet
    We believe that people can only live their healthiest lives on a healthy planet. That’s why we reduce our environmental footprint by finding...
  4. Policy and Regulation
    Cascale shares insights regarding policy and regulation impacting the consumer goods industry, and highlights how it's supporting members prepare for...
  5. Collective Action
    Cascale shares updates on its efforts and initiatives geared toward activating its ecosystem to develop and scale solutions that drive collective...
  6. Responsible Investing
    Responsible Investing
  7. Rethinking EHS Podcast
    Join us as we travel the world to uncover real stories of impact—from landfills and energy transition to workplace safety, emerging contaminants, and...
  8. IWBI | Community News
    We believe that people's health and wellness should be at the center of design. That’s why we’re working with industry professionals in real estate...
  9. Arbor Day Foundation News
    Stay up to date on the latest news and events from the Arbor Day Foundation. Subscribe to the Arbor Day e-news arborday.org/accounts/optin.cfm
  10. Drawdown Georgia
    Informed by Project Drawdown, the world’s leading resource for climate solutions, Drawdown Georgia is the first state-centered effort to crowdsolve...